Yayın: Significance of nm23 immunoexpression in the prognosis of renal cell carcinoma
| dc.contributor.buuauthor | Filiz, Gülaydan | |
| dc.contributor.buuauthor | Adım, Şaduman Balaban | |
| dc.contributor.buuauthor | Aytaç, Berna | |
| dc.contributor.buuauthor | Akar, Eylem | |
| dc.contributor.buuauthor | Vuruşkan, Hakan | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Üroloji Ana Bilim Dalı | |
| dc.contributor.department | Tıbbi Patoloji Ana Bilim Dalı | |
| dc.contributor.researcherid | AAH-9746-2021 | |
| dc.contributor.scopusid | 6602693514 | |
| dc.contributor.scopusid | 15730076300 | |
| dc.contributor.scopusid | 56527372000 | |
| dc.contributor.scopusid | 26634688200 | |
| dc.contributor.scopusid | 6507328150 | |
| dc.date.accessioned | 2022-02-11T09:47:05Z | |
| dc.date.available | 2022-02-11T09:47:05Z | |
| dc.date.issued | 2010 | |
| dc.description.abstract | Non-metastatic gene 23 (nm23) is a metastasis suppressor gene that is expressed in all tissues and decreased nm23 expression may be linked to poor prognosis. By immunohistochemical staining of nm23 protein antibodies this study examined the prognostic value of nm23 protein expression in 54 renal cell carcinoma (RCC) patients and analysed its relationship with tumour, node, metastases (TNM) surgical stage, Fuhrman nuclear grade, lymph node involvement and survival. Of the 54 RCC cases studied, 11 (20.4%) showed positive lymph node involvement while 43 (79.6%) were lymph node negative. There was no difference in nm23 protein expression between cases with and without lymph node involvement. In addition, nm23 protein expression was not related to TNM stage, Fuhrman nuclear grade or survival. More extensive studies are required to understand the effect of nm23 protein expression on the biological behaviour of RCC. | |
| dc.identifier.citation | Filiz, G. vd. (2010): "Significance of nm23 immunoexpression in the prognosis of renal cell carcinoma". Journal of International Medical Research, 38(2), 620-624. | |
| dc.identifier.doi | 10.1177/147323001003800224 | |
| dc.identifier.endpage | 624 | |
| dc.identifier.issn | 0300-0605 | |
| dc.identifier.issn | 1473-2300 | |
| dc.identifier.issue | 2 | |
| dc.identifier.pubmed | 20515575 | |
| dc.identifier.scopus | 2-s2.0-77953692852 | |
| dc.identifier.startpage | 620 | |
| dc.identifier.uri | https://doi.org/10.1177/147323001003800224 | |
| dc.identifier.uri | https://journals.sagepub.com/doi/10.1177/147323001003800224 | |
| dc.identifier.uri | http://hdl.handle.net/11452/24417 | |
| dc.identifier.volume | 38 | |
| dc.identifier.wos | 000279877200024 | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Sage Publications | |
| dc.relation.journal | Journal of International Medical Research | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Renal cell carcinoma | |
| dc.subject | NM23 | |
| dc.subject | Immunohistochemistry | |
| dc.subject | Prognosis | |
| dc.subject | Expression | |
| dc.subject | Protein | |
| dc.subject | Metastasis | |
| dc.subject | Association | |
| dc.subject | Cancer | |
| dc.subject | Stage | |
| dc.subject | Research & experimental medicine | |
| dc.subject | Pharmacology & pharmacy | |
| dc.subject.emtree | Non metastatic gene 23 protein | |
| dc.subject.emtree | Tumor suppressor protein | |
| dc.subject.emtree | Unclassified drug | |
| dc.subject.emtree | Adult | |
| dc.subject.emtree | Aged | |
| dc.subject.emtree | Article | |
| dc.subject.emtree | Cancer classification | |
| dc.subject.emtree | Cancer staging | |
| dc.subject.emtree | Controlled study | |
| dc.subject.emtree | Female | |
| dc.subject.emtree | Follow up | |
| dc.subject.emtree | Fuhrman nuclear grade | |
| dc.subject.emtree | Human | |
| dc.subject.emtree | Human tissue | |
| dc.subject.emtree | Immunohistochemistry | |
| dc.subject.emtree | Immunoreactivity | |
| dc.subject.emtree | Kidney carcinoma | |
| dc.subject.emtree | Lymph node metastasis | |
| dc.subject.emtree | Major clinical study | |
| dc.subject.emtree | Male | |
| dc.subject.emtree | Prognosis | |
| dc.subject.emtree | Protein expression | |
| dc.subject.emtree | Protein localization | |
| dc.subject.emtree | Survival time | |
| dc.subject.emtree | Tumor suppressor gene | |
| dc.subject.scopus | Nucleoside-Diphosphate Kinase; Suppressors; Prunes | |
| dc.subject.wos | Medicine, research & experimental | |
| dc.subject.wos | Pharmacology & pharmacy | |
| dc.title | Significance of nm23 immunoexpression in the prognosis of renal cell carcinoma | |
| dc.type | Article | |
| dc.wos.quartile | Q4 | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/Tıbbi Patoloji Ana Bilim Dalı | |
| local.contributor.department | Tıp Fakültesi/Üroloji Ana Bilim Dalı | |
| local.indexed.at | PubMed | |
| local.indexed.at | WOS |
Dosyalar
Lisanslı seri
1 - 1 / 1
